Siana Capital

Siana Capital is a Bengaluru-based mid-market technology-focused VC writing $5M to $25M checks at Series B and Series C into AI and deep-tech platforms targeting both Indian and global markets. The fund occupies a relatively scarce position in the Indian venture landscape: a growth-stage technology investor that focuses on enterprise and platform plays rather than consumer internet or marketplace businesses. Within healthcare, Siana is interested in health IT software and AI/ML applications with clear enterprise GTM and recurring revenue, and the firm’s stage focus means it wants to see companies that have already cleared Series A, demonstrated product-market fit, and built credible commercial machinery. The geographic remit straddles India and global markets, which suits founders building India-first companies that already have international ambitions or US-market traction with Indian operating leverage. The right founder profile is a CEO running a Series B-ready company with genuine technical depth, a clean ARR profile, defensible enterprise customer concentration logic, and a credible global expansion thesis. The wrong fit is a pre-revenue research-stage company, a consumer brand without B2B economics, or a company that needs deep clinical-domain operating support; Siana is a growth-stage tech investor, not a healthcare specialist. The right entry path is through warm introductions from Series A leads who frequently syndicate growth rounds, including firms like Lightspeed, Accel, and Sequoia India, and through Bengaluru-based operator networks where Siana’s partners are active. The firm is reachable through targeted outreach when the Series B metrics are strong, but warm intros materially improve diligence speed. When pitching, lead with the ARR trajectory, gross retention, net retention, sales efficiency, and the international expansion playbook; AI capability is welcome but does not substitute for enterprise sales metrics. Caveats: Siana’s healthcare-specific operating expertise is generalist rather than specialist, so founders should layer clinical-domain advisors and co-investors onto the cap table to round out diligence and operating support. Use Siana when you are running a venture-scale technology business with healthcare exposure and you need a growth-stage capital partner who can underwrite a global trajectory.